The Molecular Heterogeneity of NRAS Variants in Thyroid Nodules
Otolaryngology–Head and Neck Surgery · 2026-08 · 175 (2) · 343-349
DOI: 10.1002/ohn.70298 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, published online on 2026-06-17. Written by Emma De Ravin and 5 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: GTP Phosphohydrolases, Membrane Proteins, Thyroid Nodule, Mutation. Cited 1 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Objective
NRAS variants are the most common mutations in thyroid nodules with (B)ethesda III/IV cytology. This study aims to characterize co‐occurring variants, molecular signatures, and hallmarks of cancer pathways in nodules with NRAS variants. Study Design Retrospective database analysis.
Methods
The database of nodules sent for Afirma GSC testing was analyzed for the most common NRAS hotspot mutations, co‐occurring mutations, BRAF‐RAS score (BRS), thyroid differentiation score (TDS), ERK expression, and activity levels of hallmarks of cancer pathways.
Results
Of 87,817 Afirma GSC‐suspicious or BV/VI nodules, 12.6% had NRAS mutations. Of those, 79.7% were NRAS p.Q61R and 19.4% were NRAS p.Q61K. 421 nodules (3.8%) had co‐occurring mutations, EIF1AX being the most common (1%, about twice the rate seen alone). Of 872 nodules with TERT promoter mutations ( TERTp ), 7.8% had concurrent NRAS + TERT mutations (more than twice the rate of TERT alone). The presence of NRAS (+/− co‐mutations) was highly RAS‐ like on the BRS score. Hallmarks of cancer pathways analyzed across NRAS + nodules, with TERTp profiling, revealed 2 distinct clusters: one with higher inflammatory pathway activity, and another with higher DNA repair, estrogen response, and MYC activity. The latter had a higher rate of BV/VI nodules. NRAS p.Q61R was equally distributed across the 2 clusters.
Conclusion
NRAS p.Q61R/K comprises 99% of reported NRAS variants. TERTp is the most frequent co‐mutation. Among NRAS p.Q61R/K nodules, there are 2 different clusters of samples based on the activity of hallmarks of cancer pathways. Further studies correlating these clusters with clinical and pathological outcomes are necessary.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
- Veracyte Inc., South San Francisco, California, USA.
ORCID profiles: Emma De Ravin
Cite
APA
Ravin, E., Alshalalfa, M., Jiang, R., Hao, Y., Klopper, J. P., & Cottrill, E. (2026). The Molecular Heterogeneity of NRAS Variants in Thyroid Nodules. Otolaryngology–Head and Neck Surgery, 175(2), 343-349. https://doi.org/10.1002/ohn.70298
Vancouver
Ravin E, Alshalalfa M, Jiang R, Hao Y, Klopper JP, Cottrill E. The Molecular Heterogeneity of NRAS Variants in Thyroid Nodules. Otolaryngology–Head and Neck Surgery. 2026;175(2):343-349. doi:10.1002/ohn.70298
BibTeX
@article{Ravin2026,
author = {Ravin, Emma De and Alshalalfa, Mohammed and Jiang, Ruochen and Hao, Yangyang and Klopper, Joshua P and Cottrill, Elizabeth},
title = {The Molecular Heterogeneity of NRAS Variants in Thyroid Nodules},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2026},
volume = {175},
number = {2},
pages = {343--349},
doi = {10.1002/ohn.70298}
}
EUVIMED